Augments our existing ARDS trial tremendously.
Our case simply gets stronger.
Keep calm and carry on holding
What!
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-92
-
- There are more pages in this discussion • 334 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.5¢ |
Change
0.005(0.53%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 96.0¢ | 93.5¢ | $2.477M | 2.610M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 14809 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 10582 | 1 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |